硼替佐米耐药多发性骨髓瘤细胞基因表达谱分析
A microarray analysis of bortezomib-resistant gene expression in multiple myeloma

DOI: 10.6040/j.issn.1671-7554.0.2014.944

Keywords: 多发性骨髓瘤,硼替佐米,耐药,基因芯片,
Multiple myeloma,Drug resistance,Bortezomib,cDNA microarray

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Palumbo A, Ambrosini MT, Benevolo G, et al. Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma[J]. Blood, 2007, 109(7):2767-2772.
[2]	Takagi Y, Nozaki K, Sugino T, et al. Phosphorylation of c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinase after transient forebrain ischemia in mice[J]. Neurosci Lett, 2000, 294(2):117-120.
[3]	Duan Z, Choy E, Harmon D, et al. ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines[J]. PLoS One, 2009, 6(9):728-732.
[4]	Kutok JL, Yang X, Folkerth R, et al. Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues[J]. J Cell Mol Med, 2011, 15(1):86-93.
[5]	Zheng B, Zhou R, Gong Y, et al. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemia cell lines[J]. Biochemical Int J Lab Hematol, 2012, 34(3):237-247.
[6]	Berenson JR, Yang HH, Sadler K, et al. Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma[J]. J Clin Oncol, 2006, 24(6):937-944.
[7]	Richardsom PG, Xie W, Jagannath S, et al. A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma[J]. Blood, 2014, 123(10):1461-1469.
[8]	Chauhan D, Li G, Shringarpure R, et al. Blockade of Hsp27 overcomes bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells[J]. Cancer Res, 2003, 63(69):6174-6177.
[9]	Oerlemans R, Franke NE, Assaraf YG, et al. Molecular basis of bortezomib resistance:proteasome subunit beta5(PSMB5) gene mutation and overexpression of PSMB5 protein[J]. Blood, 2008, 112(6):2489-2499.
[10]	Mitsiades N, Mitsiades CS, Poulaki V, et al. Molecular sequelae of proteasome inhibitionin human multiple myeloma cells[J]. Proc Natl Acad Sci USA, 2002, 99(22):14374-14379.
[11]	蒲业迪, 李丽珍, 马道新, 等. 硼替佐米耐药多发性骨髓瘤细胞株KM3/BTZ的建立[J]. 山东大学学报:医学版, 2013, 51(2):33-36. PU Yedi, LI Lizhen, MA Daoxin, et al. Establishment of a bortezomib-resistant cell line KM3/BTZ of human multiple myeloma[J]. Journal of Shandong University:Health Sciences, 2013, 51(2):33-36.
[12]	李荣, 侯建. 新药时代造血干细胞移植治疗多发性骨髓瘤若干问题探讨[J]. 中国实用内科杂志, 2014, 34(2):115-117. LI Rong, HOU Jian. Several issues concerning hematopoietic stem cell transplantation in treatment of multiple myeloma in the new drugarea[J]. Chinese Journal of Practical Internal Medicine, 2014, 34(2):115-117.
[13]	Liang Y, Tedder TF. Identification of a CD20-, FcepsilonRIbeta-, and HTm4 related gene family:sixteen new MS4A family members expressed in human and mouse[J]. Genomics, 2001, 72(2):119-127.
[14]	Huebner K, Druck T, Croce C, et al. Twenty-seven nonoverlapping zinc finger cDNAs from human T cells map to nine different chromosomes with apparent clustering[J]. Am J Hum Genet, 1991, 48(4):726-740.
[15]	Carrasco DR, Sukhdeo K, Protopopova M, et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis[J]. Cancer Cell, 2007, 411(4):349-360.
[16]	Teru Hideshima, Klaus Podar, Dharminder Chauhan, et al. p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells[J]. Oncogene, 2004, 23(54):8766-8776.
[17]	Wang BD, Kline CL, Pastor DM, et al. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network[J]. Mol Cancer, 2010, 430(9):1186-1476.
[18]	Shringarpure R, Catley L, Bhole D, et al.Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib[J]. Br J Haematol, 2006, 134(2):145-156.
[19]	Hoovers J, Mannens M, John R, et al. High-resolution localization of 69 potential human zinc finger protein genes:A number are clustered[J]. Genomics, 1992, 12(2):254-263.
[20]	Liang Y, Buckley TR, Tu L, et al. Structural organization of the human MS4A gene cluster on Chromosome 11q12[J]. Immunogenetics, 2001, 53(5):357-368.

Full-Text